DAS released from albumin NPs can then bind to Src and BCR-ABL tyrosine kinases and inhibit their autophosphorylation along with their downstream targets leading to blockade of the oncogenic activities of leukemia cells [30, 31]. The gene discussed is ABL1; the disease is leukemia.